Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioPharmX Corporation (BPMX)

0.3862   -0.035 (-8.31%) 12-06 16:00
Open: 0.41 Pre. Close: 0.4212
High: 0.4085 Low: 0.3402
Volume: 1,233,455 Market Cap: 5M
BioPharmX Corp is a specialty pharmaceutical company. It is engaged in utilizing its proprietary drug delivery technologies to develop & commercialize novel prescription & over-the-counter, products that address markets in women's health & dermatology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.41 - 0.412 0.412 - 0.414
Low: 0.336 - 0.338 0.338 - 0.34
Close: 0.386 - 0.39 0.39 - 0.393

Technical analysis

as of: 2019-12-06 4:33:04 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.51     One year: 0.59
Support: Support1: 0.32    Support2: 0.26
Resistance: Resistance1: 0.43    Resistance2: 0.51
Pivot: 0.30
Moving Average: MA(5): 0.36     MA(20): 0.29
MA(100): 0.34     MA(250): 1.29
MACD: MACD(12,26): 0.02     Signal(9):
Stochastic oscillator: %K(14,3): 83.81     %D(3): 84.25
RSI: RSI(14): 68.20
52-week: High: 4.47  Low: 0.26  Change(%): -88.1
Average Vol(K): 3-Month: 35719  10-Days: 64252

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BPMX has closed below upper band by 6.5%. Bollinger Bands are 109% wider than normal. The large width of the bands suggest high volatility as compared to BPMX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO ) Allakos Inc (NASDAQ: ALLK ) Cytokinetics, Inc. (NASDAQ: CYTK ) Guardant Health Inc (NASDAQ: GH ) (reacted to strong second-quarter results) Morphic Holding Inc (NASDAQ: MORF ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 7) ABIOMED, Inc. (NASDAQ: ABMD ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioCardia Inc (NASDAQ: BCDA ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Biopharmx Corp NYSE: (BPMX) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Cellular Biomedicine Group Inc (NASDAQ: CBMG )(reacted to second-quarter results) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(reported second-quarter results) Guardion Health Sciences Inc (NASDAQ: GHSI )(announced common stock offering of 9.

The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 10.68
Shares Float (M) 13.26
% Held by Insiders 1.64
% Held by Institutions 18.95
Shares Short (K) 75
Shares Short P. Month (K)

Stock Financials

EPS -1.558
Book Value (p.s.) 0.160
PEG Ratio
Profit Margin
Operating Margin -91623.33
Return on Assets (ttm) -136.4
Return on Equity (ttm) -454.5
Qtrly Rev. Growth
Gross Profit (p.s.) -0.002
Sales Per Share
EBITDA (p.s.) -1.281
Qtrly Earnings Growth
Operating Cash Flow (M) -13.60
Levered Free Cash Flow (M) -8.35

Stock Valuations

P/E -0.25
P/E Growth Ratio -0.08
P/BV 2.41
P/CF -0.30

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-04-26
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.